Triumph Bancorp Announces Closing of $50 million of Fixed-to-Floating Rate Subordinated Notes
September 30, 2016 16:50 ET
|
Triumph Bancorp, Inc.
DALLAS, Sept. 30, 2016 (GLOBE NEWSWIRE) -- Triumph Bancorp, Inc. (NASDAQ:TBK) (“Triumph” or the “Company”) today closed its public offering of $50 million aggregate principal amount of its...
Scott + Scott, LLP Announces Investigation of Zosano Pharma Corp (ZSAN), Encourages Investors with Losses to Contact Firm
September 29, 2016 11:41 ET
|
Scott + Scott, Attorneys at Law, LLP
NEW YORK, Sept. 29, 2016 (GLOBE NEWSWIRE) -- Scott + Scott, Attorneys at Law, LLP, a global shareholder rights litigation firm, has opened an investigation on behalf of investors in Zosano Pharma...
NewStar Capital Sponsors Seventh Loan Fund
September 21, 2016 08:00 ET
|
NewStar Financial, Inc.
Boston, MA, Sept. 21, 2016 (GLOBE NEWSWIRE) -- NewStar Financial, Inc. (Nasdaq:NEWS), an internally-managed commercial finance company and asset manager, announced today that its liquid credit...
Innocoll Holdings plc Announces Closing of Public Offering
June 22, 2016 16:30 ET
|
Innocoll Holdings plc
ATHLONE, Ireland, June 22, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a specialty pharmaceutical and medical device company with late stage development programs targeting areas...
Innocoll Holdings plc Announces Pricing of Public Offering of Ordinary Shares
June 16, 2016 22:00 ET
|
Innocoll Holdings plc
ATHLONE, Ireland, June 16, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical and medical device company with late stage development programs...
Innocoll Holdings plc Announces Proposed Public Offering of Ordinary Shares
June 13, 2016 16:15 ET
|
Innocoll Holdings plc
ATHLONE, Ireland, June 13, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL) a global, specialty pharmaceutical and medical device company with late stage development programs targeting...
Cempra Completes Public Offering of Common Stock
January 12, 2016 16:05 ET
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Jan. 12, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra Prices Public Offering of Common Stock
January 06, 2016 20:42 ET
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Otonomy Announces Pricing of Public Offering of Common Stock
January 06, 2016 19:39 ET
|
Otonomy, Inc.
SAN DIEGO, Jan. 06, 2016 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases...
NewStar Announces Pricing of Senior Note Offering and Increases Size to $80 Million
November 09, 2015 18:15 ET
|
NewStar Financial, Inc.
BOSTON, Nov. 09, 2015 (GLOBE NEWSWIRE) -- NewStar Financial, Inc. (Nasdaq:NEWS) ("NewStar") announced today that it priced its previously announced offering of senior notes, consisting of $80...